About Samira Tatiyama Miyamoto, PhD
Clinical Trials at Samira Tatiyama Miyamoto, PhD
During the past decade, Samira Tatiyama Miyamoto, PhD conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Samira Tatiyama Miyamoto, PhD
According to Clinical.Site data, the most researched conditions in "Samira Tatiyama Miyamoto, PhD" are
"Dermatomyositis" (1 trials), "Idiopathic Inflammatory Myopathy" (1 trials), "Polymyositis" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Samira Tatiyama Miyamoto, PhD" in a lesser frequency.
Clinical Trials Intervention Types at Samira Tatiyama Miyamoto, PhD
Most popular intervention types in "Samira Tatiyama Miyamoto, PhD" are "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Educational intervention" (1 trials), "Repetitive task training" (1 trials), "Resistance training" (1 trials) and "SARAH" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Samira Tatiyama Miyamoto, PhD
The vast majority of trials in "Samira Tatiyama Miyamoto, PhD" are
1 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Samira Tatiyama Miyamoto, PhD
Currently, there are NaN active trials in "Samira Tatiyama Miyamoto, PhD".
1 are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Samira Tatiyama Miyamoto, PhD,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Samira Tatiyama Miyamoto, PhD, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".